Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay

Cardiotoxicity has emerged as a major side effect of doxorubicin (DOX) treatment, affecting nearly 30% of patients within 5 years after chemotherapy. Heart failure is the first non-cancer cause of death in DOX-treated patients. Although many different molecular mechanisms explaining the cardiac dera...

Description complète

Détails bibliographiques

Auteurs principaux:	Leonardo Schirone, Luca D’Ambrosio, Maurizio Forte, Riccardo Genovese, Sonia Schiavon, Giulia Spinosa, Giuliano Iacovone, Valentina Valenti, Giacomo Frati, Sebastiano Sciarretta
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-06-01
Collection:	Cells
Sujets:	DOX anthracycline cardiomyopathy mitochondria heart
Accès en ligne:	https://www.mdpi.com/2073-4409/11/13/2000
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!